Journal of Drug Delivery Science and Technology

Papers
(The H4-Index of Journal of Drug Delivery Science and Technology is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
99mTc Radionuclide-labeled and hydrogel-coated BaTiO3 nanocomposites196
Biopharmaceutical modulatory effects of newly engineered bile acid-Tyloxapol nanogels for attenuation of cytotoxicity in auditory cells175
NiWo4- RGO composite exerts cytotoxic effects on pancreatic carcinoma cells via a cross-talk between reactive oxygen species-independent canonical autophagy of the mitochondria and epithelial-mesenchy155
Supramolecular hydrogel of mycophenolic acid for treating allergic conjunctivitis119
Hepatoprotective effects of Oxalis debilis-derived zinc oxide nanoparticles against CCl4-Induced oxidative stress via NF-ҡB modulation114
Evaluation of preclinical efficacy of apremilast-loaded liquid crystalline nanoparticulate gel in amelioration of atopic dermatitis108
Synergy between cyclooxygenase-2 inhibitors and hyaluronic acid in the treatment of osteoarthritis: Illumination of signaling cascade, nanotechnology-driven delivery strategies and future prospects105
Bergenin nano-lipid carrier to improve the oral delivery: Development, optimization, in vitro and in vivo evaluation93
Development and in vitro effects of thiolated chitosan nanoparticles for the sustained delivery of inflammation suppressing bioactive peptide91
Polysaccharide-silicate composite hydrogels: Review on synthesis and drug delivery credentials84
Esterified gellan gum microparticles for sustained release of aceclofenac: Preparation, characterization and in vitro-in vivo evaluations82
Cholecalciferol-grafted hollow mesoporous silica nanoparticles for targeted and sustained caffeine delivery in alopecia therapy81
Thioether choline phosphate liposomes for reactive oxygen species-trigger drug release80
Design of an oral formulation combining PVA nanofibers and PEGylated liposomes for enhanced drug delivery72
Development, characterization of naringenin-loaded promising microemulsion formulations, and demonstration of anti-aging efficacy by in vitro enzyme activity and gene expression71
Nanoemulgel formulation for topical delivery of plant glucosylceramide: Characterization and optimization69
Application of nanotechnology to improve the antileishmanial efficacy of amphotericin B69
Camptothecin-loaded and IR780-doped polydopamine nanomedicine used for multifunctional chemo-photothermal-photodynamic therapy for lung cancer69
Validated correlation of mass loss and drug release in vitro and in healthy subjects for sugared and sugar-free cetylpyridinium chloride (CPC) and benzocaine (1.4 mg/10 mg) lozenges supports in vitro 67
Graphical Abstract TOC67
Tumor-microenvironment double-responsive shrinkable nanoparticles fabricated via facile assembly of laponite with a bioactive oligosaccharide for anticancer therapy63
Biorelevant in vitro drug release conditions ameliorate in-vitro-in-vivo relationship of parenteral risperidone microspheres60
Maintaining supersaturation generation and protein integrity of amorphous curcumin-albumin nanoplex during storage by freeze drying with trehalose59
Scrophularia striata extract incorporated nanofibrous scaffold improved osteogenic differentiation of mesenchymal stem cells59
In vitro and in vivo evaluation of the layer-by-layer vancomycin with poly(ε-caprolactone) nanosphere-coated Schanz pins for prolonged release56
Hot melt extrusion for enhanced dissolution and intestinal absorption of hydrochlorothiazide55
Preparation and biological evaluation of novel 5-Fluorouracil and Carmofur loaded polyethylene glycol / rosin ester nanocarriers as potential anticancer agents and ceramidase inhibitors54
Advancements in ischemic stroke management: Transition from traditional to nanotechnological approaches53
Editorial Board53
Propellant-free foam formulation with tamanu oil microemulsion and nanocurcumin for enhanced burn healing52
Conjugation of folic acid onto poly (acrylic acid-co-allylamine)-grafted mesoporous silica nanoparticles for controlled methotrexate delivery52
Novel solid self-emulsifying drug delivery system to improve the physical performance and bioavailability of supercritical fluid extracts of frankincense and myrrh51
Evaluating the efficacy of bilosomes as a promising nanovector for methotrexate against breast cancer51
Advanced wound healing: The synergy of nature and nanotechnology51
Does binary blend emulsifier enhance emulsifier performance? Preparation of baicalin nanoemulsions using tea saponins and glycyrrhizic acid as binary blend emulsifier50
Development and evaluation of a spray formulation combining triamcinolone acetonide and lidocaine for enhanced healing of mouth ulcers48
Nanomedicines for ocular fibrosis48
3D-printed short nanofibers/hydrogel-based vaginal films as a novel system for the delivery of anti-HIV microbicide drugs48
A ZIF-8 nano drug delivery system that inhibits protective autophagy in cancer cells for enhancing photothermal antitumor therapy47
Tumor-associated inflammation: The role and research progress in tumor therapy47
Development and evaluation of a sustained release solid dispersion of cefdinir using a hydrophobic polymeric carrier and aminoclay46
Assembly of two palmatine pharmaceutical salts: Changing the motifs and affecting the physicochemical properties by adjusting the position of –COOH on salt formers46
NIR-activated magnetic resonance nanoprobes for combined photothermal therapy and chemotherapy of cancer46
A thermoresponsive system of niclosamide for colon specific delivery in ulcerative colitis: Bioavailability and safety investigation45
Production and evaluation of polymer filaments for potential use in 3D printing of bioresorbable drug-eluting stents45
Development of printable inks for 3D printing of personalized dosage forms: Coupling of fused deposition modelling and jet dispensing45
Chewing gum containing repaglinide solid dispersion using mesoporous silica nanoparticles for management of diabetes mellitus: In-vitro evaluation and clinical appraisal45
0.17467212677002